MX2012002677A - Forma farmaceutica oral, que consta de al menos un agente activo, sustancias auxiliares de formulacion y particulas magnetizables. - Google Patents
Forma farmaceutica oral, que consta de al menos un agente activo, sustancias auxiliares de formulacion y particulas magnetizables.Info
- Publication number
- MX2012002677A MX2012002677A MX2012002677A MX2012002677A MX2012002677A MX 2012002677 A MX2012002677 A MX 2012002677A MX 2012002677 A MX2012002677 A MX 2012002677A MX 2012002677 A MX2012002677 A MX 2012002677A MX 2012002677 A MX2012002677 A MX 2012002677A
- Authority
- MX
- Mexico
- Prior art keywords
- dosage form
- auxiliary substances
- magnetizable particles
- formulation auxiliary
- active agent
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 238000009472 formulation Methods 0.000 title abstract 4
- 239000002245 particle Substances 0.000 title abstract 4
- 239000000126 substance Substances 0.000 title abstract 3
- 239000013543 active substance Substances 0.000 title abstract 2
- 239000006186 oral dosage form Substances 0.000 title abstract 2
- 239000002552 dosage form Substances 0.000 abstract 2
- 238000001514 detection method Methods 0.000 abstract 1
- 238000011156 evaluation Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4833—Encapsulating processes; Filling of capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23961309P | 2009-09-03 | 2009-09-03 | |
| DE102009029170 | 2009-09-03 | ||
| PCT/EP2010/062641 WO2011026808A1 (en) | 2009-09-03 | 2010-08-30 | Oral dosage form, comprising at least one biologically active agent, formulation auxiliary substances and magnetizable particles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2012002677A true MX2012002677A (es) | 2012-04-11 |
Family
ID=42984007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012002677A MX2012002677A (es) | 2009-09-03 | 2010-08-30 | Forma farmaceutica oral, que consta de al menos un agente activo, sustancias auxiliares de formulacion y particulas magnetizables. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9050256B2 (enExample) |
| EP (1) | EP2473095B1 (enExample) |
| JP (1) | JP5868319B2 (enExample) |
| KR (1) | KR101731130B1 (enExample) |
| CN (1) | CN102573612B (enExample) |
| BR (1) | BR112012004967B8 (enExample) |
| CA (1) | CA2772708C (enExample) |
| ES (1) | ES2528494T3 (enExample) |
| IL (1) | IL217897A (enExample) |
| MX (1) | MX2012002677A (enExample) |
| PL (1) | PL2473095T3 (enExample) |
| SI (1) | SI2473095T1 (enExample) |
| WO (1) | WO2011026808A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014527968A (ja) * | 2011-09-14 | 2014-10-23 | ユニバーシティ オブ フロリダ | Ｓｍａｒｔ（商標）固体経口剤 |
| DE102011089334A1 (de) * | 2011-12-21 | 2013-06-27 | Evonik Röhm Gmbh | Detektionssystem zur Erfassung magnetischer Objekte im menschlichen Organismus |
| US11667906B2 (en) * | 2014-11-24 | 2023-06-06 | Corning Incorporated | Magnetic microcarriers |
| US11024449B2 (en) * | 2017-06-06 | 2021-06-01 | Apple Inc. | Multipole elastomeric magnet with magnetic-field shunt |
| JP2021505866A (ja) | 2017-12-04 | 2021-02-18 | エボニック オペレーションズ ゲーエムベーハー | ２つの材料の組み合わせを用いたｅｓｒ信号のマスキングおよびその後の視覚化 |
| US10824822B2 (en) * | 2019-02-05 | 2020-11-03 | International Business Machines Corporation | Magnetic tracking for medicine management |
| US10679018B1 (en) | 2019-02-05 | 2020-06-09 | International Business Machines Corporation | Magnetic tracking for medicine management |
| JP7502741B2 (ja) * | 2019-09-26 | 2024-06-19 | スピンセンシングファクトリー株式会社 | 磁気マーカーおよび磁気マーカー検出システム |
| TW202229560A (zh) | 2020-10-09 | 2022-08-01 | 賓州大學委員會 | 治療法布瑞氏症之組成物及方法 |
| CN112360304A (zh) * | 2020-11-06 | 2021-02-12 | 炫丽建材江苏有限公司 | 一种适用于22度免拉手门板的自愈合封边工艺 |
| JP2023553010A (ja) | 2020-12-03 | 2023-12-20 | バテル・メモリアル・インスティテュート | 非ウイルス性送達のためのポリマーナノ粒子およびｄｎａナノ構造組成物ならびに方法 |
| JP2024516108A (ja) | 2021-04-07 | 2024-04-12 | バテル・メモリアル・インスティテュート | 非ウイルス性担体を同定および使用するための迅速な設計、構築、試験、および学習技術 |
| KR20250007064A (ko) | 2022-04-06 | 2025-01-13 | 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 | Her2 양성 전이성 유방암 및 기타 암을 치료하기 위한 조성물 및 방법 |
| WO2023196892A1 (en) | 2022-04-06 | 2023-10-12 | The Trustees Of The University Of Pennsylvania | Passive immunization with anti- aav neutralizing antibodies to prevent off-target transduction of intrathecally delivered aav vectors |
| WO2025072751A1 (en) | 2023-09-29 | 2025-04-03 | Battelle Memorial Institute | Polymer nanoparticle compositions for in vivo expression of polypeptides |
| WO2025122954A1 (en) | 2023-12-08 | 2025-06-12 | Battelle Memorial Institute | Use of dna origami nanostructures for molecular information based data storage systems |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3723310A1 (de) * | 1987-07-15 | 1989-01-26 | John Urquhart | Pharmazeutisches praeparat und verfahren zu seiner herstellung |
| DE3740187A1 (de) | 1987-11-27 | 1989-06-08 | Urquhart John | Verfahren und vorrichtung zum ueberwachen und/oder kontrollieren und/oder registrieren und/oder anzeigen der einnahme von pharmazeutischen praeparaten |
| DE3940260A1 (de) | 1989-03-04 | 1990-09-13 | Werner Weitschies | Verfahren zur bestimmung des aufenthaltsortes und der bewegung von objekten durch ihre markierung als magnetisches moment |
| CN1056049C (zh) | 1994-02-02 | 2000-09-06 | 湖南省商业科技研究所 | 一种磁疗食品的制备方法 |
| EP0928155A1 (de) | 1996-08-16 | 1999-07-14 | Roche Diagnostics GmbH | Kontrollsystem für die überwachung der regelmässigen einnahme eines medikamentes |
| JP2004331750A (ja) | 2003-05-02 | 2004-11-25 | Canon Inc | ポリヒドロキシアルカノエートを含有する磁性構造体及びその製造方法ならびにその用途 |
| EP1557151A1 (en) * | 2004-01-22 | 2005-07-27 | F. Hoffmann-La Roche Ag | Solid dosage form |
| CN100355454C (zh) * | 2005-10-25 | 2007-12-19 | 南京工业大学 | 磁热疗用纳米磁粉－抗人肝癌单抗HAb18靶向药物 |
| EP1880716A1 (en) | 2006-07-19 | 2008-01-23 | Sandoz AG | Kit of parts comprising an acid labile and an acid resistant pharmaceutically active ingredient |
| DE102008033662A1 (de) | 2008-07-11 | 2010-01-14 | Technische Universität Ilmenau | Pharmakologische Darreichungsform und Vorrichtung und Verfahren zur kontinuierlichen Lokalisierung und Verfolgung des Auflösevorganges dieser |
-
2010
- 2010-08-30 PL PL10747220T patent/PL2473095T3/pl unknown
- 2010-08-30 SI SI201030850T patent/SI2473095T1/sl unknown
- 2010-08-30 BR BR112012004967A patent/BR112012004967B8/pt not_active IP Right Cessation
- 2010-08-30 CA CA2772708A patent/CA2772708C/en active Active
- 2010-08-30 MX MX2012002677A patent/MX2012002677A/es active IP Right Grant
- 2010-08-30 US US13/390,353 patent/US9050256B2/en active Active
- 2010-08-30 WO PCT/EP2010/062641 patent/WO2011026808A1/en not_active Ceased
- 2010-08-30 EP EP10747220.1A patent/EP2473095B1/en active Active
- 2010-08-30 JP JP2012527293A patent/JP5868319B2/ja not_active Expired - Fee Related
- 2010-08-30 CN CN201080039021.4A patent/CN102573612B/zh not_active Expired - Fee Related
- 2010-08-30 ES ES10747220.1T patent/ES2528494T3/es active Active
- 2010-08-30 KR KR1020127005600A patent/KR101731130B1/ko not_active Expired - Fee Related
-
2012
- 2012-02-02 IL IL217897A patent/IL217897A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| KR101731130B1 (ko) | 2017-05-11 |
| US9050256B2 (en) | 2015-06-09 |
| EP2473095B1 (en) | 2014-11-12 |
| US20120143039A1 (en) | 2012-06-07 |
| CN102573612B (zh) | 2015-07-08 |
| SI2473095T1 (sl) | 2015-02-27 |
| CA2772708C (en) | 2017-07-11 |
| PL2473095T3 (pl) | 2015-04-30 |
| BR112012004967B1 (pt) | 2021-05-11 |
| EP2473095A1 (en) | 2012-07-11 |
| CA2772708A1 (en) | 2011-03-10 |
| JP5868319B2 (ja) | 2016-02-24 |
| HK1168016A1 (en) | 2012-12-21 |
| KR20120060210A (ko) | 2012-06-11 |
| JP2013503831A (ja) | 2013-02-04 |
| CN102573612A (zh) | 2012-07-11 |
| WO2011026808A8 (en) | 2012-03-15 |
| WO2011026808A1 (en) | 2011-03-10 |
| BR112012004967A2 (pt) | 2016-04-05 |
| ES2528494T3 (es) | 2015-02-10 |
| IL217897A0 (en) | 2012-03-29 |
| BR112012004967B8 (pt) | 2022-07-05 |
| IL217897A (en) | 2014-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2012002677A (es) | Forma farmaceutica oral, que consta de al menos un agente activo, sustancias auxiliares de formulacion y particulas magnetizables. | |
| IL274829B (en) | A pharmaceutical preparation containing an echinocandin compound and the use of a freeze-dried preparation containing an echinocandin compound in the preparation of an aqueous solution for the treatment of a fungal infection | |
| EA201400972A1 (ru) | Лекарственные формы немедленного высвобождения с защитой от несанкционированного применения | |
| MX2023008180A (es) | Una composicion farmaceutica que comprende nanoparticulas hibridas amorfas estables, de al menos un inhibidor de proteina quinasa y al menos un componente estabilizador polimerico y formador de matriz. | |
| IL232325A0 (en) | 18-methyl-7,6-methylene-3-oxo-17-paragan-4-en-21, 17b-carbolactones, pharmaceutical preparations containing these compounds and their use for the treatment of endometrial disease | |
| MX2009005696A (es) | Nanoparticulas magneticas para la aplicacion en hipertermia, preparacion de las mismas y uso en constructos que tienen una aplicacion farmacologica. | |
| FR2967674B1 (fr) | Derives d'heteroarylsulfonamides, leur preparation et leur application en therapeutique humaine | |
| WO2012156317A3 (en) | Intranasal pharmaceutical dosage forms comprising naloxone | |
| IN2014MN02214A (enExample) | ||
| CL2012003012A1 (es) | Composicion farmaceutica oral de liberacion prolongada que comprenden a) al menos un material de liberacion prolongada y b) hidromorfona o una sal y naloxona o una sal en una relacion 2:1 a 1:3; metodo de preparacion. | |
| WO2012098562A3 (en) | Liquid oral compositions of lanthanum salts | |
| CL2012003168A1 (es) | Composicion farmaceutica que comprende una solucion acuosa de minociclina y un cation divalente o trivalente en una proporcion mayor de 2:1 con respecto a la minociclina; metodo de preparacion; kit y uso en el tratamiento de infecciones bacterianas. | |
| CL2012001940A1 (es) | Composiciones que comprenden extractos de andrographis paniculata combinados con extractos de ginkgo biloba complejados con fosfolípidos; y su uso en la preparación de un medicamento para el tratamiento de alzheimer y esclerosis múltiple. | |
| EP2666482A4 (en) | PARTICLE COMPOSITION AND PHARMACEUTICAL COMPOSITION WITH PARTICLE COMPOSITION | |
| BR112012016736A2 (pt) | composição , formulação farmacêutica e uso da composição" | |
| MX371297B (es) | Una composición farmacéutica que comprende nanopartículas híbridas amorfas estables, de al menos un inhibidor de proteína quinasa y al menos un componente estabilizador polimérico y formador de matriz. | |
| IN2014MN02156A (enExample) | ||
| IN2014DN11097A (enExample) | ||
| TN2011000352A1 (en) | New combination of active ingredients containing a non steroidal anti inflammatory drug and a colchicoside derivative | |
| NZ608164A (en) | Formulations for bovine granulocyte colony stimulating factor and variants thereof | |
| Rongming | Status of China Rare Earth Permanent Magnet Industry and Development Trend of the Technology | |
| WO2014165842A3 (en) | Nanoparticle formulations in biomarker detection | |
| Kim et al. | Current Problems and Development Directions of Reinforced Concrete Works | |
| UA54284U (ru) | Способ получения магнетита | |
| 郭萍 et al. | Local Magnetic Nanoparticle Delivery in Microvasculature |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |